F. B. Oldham

Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancer

SF Williams, WJ Lee, JG Bender et al. · Blood · 1996 · 181 citations · Full text

Medicine, Hematology, Oncology +14

Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer

Luis Paz‐Ares, Helen J. Ross, Mary O’Brien et al. · British Journal of Cancer · 2008 · 167 citations · Full text

Medicine, Oncology, Pharmacology +16

Highly purified CD34-positive cells reconstitute hematopoiesis.

Curt I. Civin, Thomas M. Trischmann, Nina S. Kadan‐Lottick et al. · Journal of Clinical Oncology · 1996 · 157 citations

Medicine, Hematology, Oncology +14

Randomized Phase III Trial Comparing Single-Agent Paclitaxel Poliglumex (CT-2103, PPX) with Single-Agent Gemcitabine or Vinorelbine for the Treatment of PS 2 Patients with Chemotherapy-Naïve Advanced Non-small Cell Lung Cancer

Mary O’Brien, Mark A. Socinski, Alexander Y. Popovich et al. · Journal of Thoracic Oncology · 2008 · 123 citations · Full text

Medicine, Oncology, Pharmacology +10

Dosing regimen of granulocyte-macrophage colony-stimulating factor to support dose-intensive chemotherapy.

James A. Neidhart, A Mangalik, Christine A. Stidley et al. · Journal of Clinical Oncology · 1992 · 58 citations

Medicine, Oncology, Pharmacology +17